English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Patient-reported outcomes of furmonertinib versus gefitinib in patients with locally advanced or metastatic, EGFR mutation-positive non-small cell lung cancer (FURLONG): A multicenter, double-blind, randomized phase 3 study
Shi, Yuankai; Chen, Gongyan; Wang, Xiang; Liu, Yunpeng; Wu, Lin; Hao, Yanrong; Liu, Chunling; Zhu, Shuyang; Zhang, Xiaodong; Li, Yuping; Liu, Jiwei; Cao, Lejie; Cheng, Ying; Zhao, Hui; Zhang, Shucai; Zang, Ai-min; Cui, Jiuwei; Feng, Jian; Yang, Nong; Hu, Jie
吉林大学; 南通大学; 哈尔滨医科大学; 中国医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
2023-6-1
20
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试